PVLA
$120.30-5.53%
Palvella Therapeutics Inc.Stock · HealthcareRussell 2000 0.05%Nasdaq Composite 0.004%Russell 3000 0.003%US Stock Market 0.003%
Palvella Therapeutics Inc. monthly returns
Palvella Therapeutics Inc. has averaged 2.71% per month, positive in 48% of months. Month-by-month returns for Palvella Therapeutics Inc. (PVLA) below, through October 16, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Average month
+2.7%
130 months
Best month
+90.0%
May 2017
Worst month
-80.4%
Jun 2023
Positive months
48%
of all months
Palvella Therapeutics Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -12.8% | |
| Sep 2026 | -9.6% | |
| Aug 2026 | +9.7% | |
| Jul 2026 | -9.0% | |
| Jun 2026 | +29.0% | |
| May 2026 | -7.7% | |
| Apr 2026 | +2.9% | |
| Mar 2026 | -7.7% | |
| Feb 2026 | +76.1% | |
| Jan 2026 | -26.7% | |
| Dec 2025 | +1.8% | |
| Nov 2025 | +28.7% | |
| Oct 2025 | +27.4% | |
| Sep 2025 | +15.8% | |
| Aug 2025 | +48.0% | |
| Jul 2025 | +62.3% | |
| Jun 2025 | -6.6% | |
| May 2025 | -0.6% | |
| Apr 2025 | -13.3% | |
| Mar 2025 | +44.5% | |
| Feb 2025 | +49.0% | |
| Jan 2025 | +8.3% | |
| Dec 2024 | -26.2% | |
| Nov 2024 | -5.8% | |
| Oct 2024 | +4.0% | |
| Sep 2024 | -9.9% | |
| Aug 2024 | +10.8% | |
| Jul 2024 | +69.2% | |
| Jun 2024 | -3.3% | |
| May 2024 | -13.3% | |
| Apr 2024 | -20.0% | |
| Mar 2024 | +10.9% | |
| Feb 2024 | -10.8% | |
| Jan 2024 | +1.6% | |
| Dec 2023 | -10.8% | |
| Nov 2023 | -13.9% | |
| Oct 2023 | -20.5% | |
| Sep 2023 | -12.1% | |
| Aug 2023 | +53.4% | |
| Jul 2023 | +33.1% | |
| Jun 2023 | -80.4% | |
| May 2023 | +12.2% | |
| Apr 2023 | -22.5% | |
| Mar 2023 | -34.9% | |
| Feb 2023 | -6.3% | |
| Jan 2023 | +53.8% | |
| Dec 2022 | +6.6% | |
| Nov 2022 | -12.1% | |
| Oct 2022 | -3.5% | |
| Sep 2022 | -21.2% | |
| Aug 2022 | -17.0% | |
| Jul 2022 | -5.9% | |
| Jun 2022 | +5.1% | |
| May 2022 | -36.4% | |
| Apr 2022 | -7.6% | |
| Mar 2022 | -1.9% | |
| Feb 2022 | -15.1% | |
| Jan 2022 | -3.7% | |
| Dec 2021 | +14.5% | |
| Nov 2021 | -27.9% | |
| Oct 2021 | -11.4% | |
| Sep 2021 | -4.1% | |
| Aug 2021 | +54.9% | |
| Jul 2021 | -9.1% | |
| Jun 2021 | +11.3% | |
| May 2021 | +59.3% | |
| Apr 2021 | -16.0% | |
| Mar 2021 | -5.5% | |
| Feb 2021 | +7.1% | |
| Jan 2021 | +1.6% | |
| Dec 2020 | -14.4% | |
| Nov 2020 | +16.3% | |
| Oct 2020 | +21.3% | |
| Sep 2020 | -27.6% | |
| Aug 2020 | +11.3% | |
| Jul 2020 | -17.1% | |
| Jun 2020 | -13.9% | |
| May 2020 | +35.8% | |
| Apr 2020 | +16.2% | |
| Mar 2020 | -26.7% | |
| Feb 2020 | -15.9% | |
| Jan 2020 | +2.2% | |
| Dec 2019 | -11.1% | |
| Nov 2019 | +23.0% | |
| Oct 2019 | -2.9% | |
| Sep 2019 | -26.7% | |
| Aug 2019 | -15.5% | |
| Jul 2019 | +17.0% | |
| Jun 2019 | +13.5% | |
| May 2019 | +38.5% | |
| Apr 2019 | -10.7% | |
| Mar 2019 | +11.7% | |
| Feb 2019 | +4.5% | |
| Jan 2019 | +7.9% | |
| Dec 2018 | -21.5% | |
| Nov 2018 | -17.7% | |
| Oct 2018 | -26.4% | |
| Sep 2018 | +1.1% | |
| Aug 2018 | +0.9% | |
| Jul 2018 | +8.3% | |
| Jun 2018 | -9.8% | |
| May 2018 | -11.8% | |
| Apr 2018 | -6.6% | |
| Mar 2018 | -20.0% | |
| Feb 2018 | +13.1% | |
| Jan 2018 | -0.3% | |
| Dec 2017 | +22.2% | |
| Nov 2017 | +22.4% | |
| Oct 2017 | -12.3% | |
| Sep 2017 | +4.5% | |
| Aug 2017 | +6.0% | |
| Jul 2017 | +2.8% | |
| Jun 2017 | +10.5% | |
| May 2017 | +90.0% | |
| Apr 2017 | -7.3% | |
| Mar 2017 | +27.5% | |
| Feb 2017 | -6.8% | |
| Jan 2017 | +55.9% | |
| Dec 2016 | -8.8% | |
| Nov 2016 | +2.7% |
Monthly total return (since Nov 2021)#
-50%0%50%
Nov 2021-28%
Dec 2021+15%
Jan 2022-3.7%2022
Feb 2022-15%
Mar 2022-1.9%
Apr 2022-7.6%
May 2022-36%
Jun 2022+5.1%
Jul 2022-5.9%
Aug 2022-17%
Sep 2022-21%
Oct 2022-3.5%
Nov 2022-12%
Dec 2022+6.6%
Jan 2023+54%2023
Feb 2023-6.3%
Mar 2023-35%
Apr 2023-23%
May 2023+12%
Jun 2023-80%
Jul 2023+33%
Aug 2023+53%
Sep 2023-12%
Oct 2023-20%
Nov 2023-14%
Dec 2023-11%
Jan 2024+1.6%2024
Feb 2024-11%
Mar 2024+11%
Apr 2024-20%
May 2024-13%
Jun 2024-3.3%
Jul 2024+69%
Aug 2024+11%
Sep 2024-9.9%
Oct 2024+4.0%
Nov 2024-5.8%
Dec 2024-26%
Jan 2025+8.3%2025
Feb 2025+49%
Mar 2025+45%
Apr 2025-13%
May 2025-0.62%
Jun 2025-6.6%
Jul 2025+62%
Aug 2025+48%
Sep 2025+16%
Oct 2025+27%
Nov 2025+29%
Dec 2025+1.8%
Jan 2026-27%2026
Feb 2026+76%
Mar 2026-7.7%
Apr 2026+2.9%
May 2026-7.7%
Jun 2026+29%
Jul 2026-9.0%
Aug 2026+9.7%
Sep 2026-9.6%
Oct 2026-13%
Palvella Therapeutics Inc. returns by calendar month#
Every month of every year since 2016, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -12.78% — 8th of 11 Octobers since 2016 at the last close; the average October returned -4.2%.
| Month | −95%0+95% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +6.9% | +1.6% | 64% | +55.9% 2017 | -26.7% 2026 | |
| Feb | +8.9% | +2.9% | 55% | +76.1% 2026 | -15.9% 2020 | |
| Mar | +0.4% | -1.9% | 45% | +44.5% 2025 | -34.9% 2023 | |
| Apr | -7.2% | -7.6% | 27% | +16.2% 2020 | -22.5% 2023 | |
| May | +14.6% | -0.6% | 45% | +90.0% 2017 | -36.4% 2022 | |
| Jun | -5.4% | -3.3% | 45% | +29.0% 2026 | -80.4% 2023 | |
| Jul | +14.6% | +8.3% | 64% | +69.2% 2024 | -17.1% 2020 | |
| Aug | +14.0% | +9.7% | 73% | +54.9% 2021 | -17.0% 2022 | |
| Sep | -6.9% | -9.6% | 36% | +15.8% 2025 | -27.6% 2020 | |
| Oct | -4.2% | -7.4% | 30% | +27.4% 2025 | -26.4% 2018 | |
| Nov | +1.6% | -1.6% | 50% | +28.7% 2025 | -27.9% 2021 | |
| Dec | -4.8% | -9.8% | 40% | +22.2% 2017 | -26.2% 2024 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from PVLA's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Palvella Therapeutics Inc.'s average monthly return?
- Palvella Therapeutics Inc. (PVLA) has averaged about 2.71% per month, positive in roughly 48% of months. The best month was May 2017 (+90.0%) and the worst was Jun 2023 (-80.4%).
More on Palvella Therapeutics Inc.
By month for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100